Advertisement BreedIT, Seach form KanaboSeed to develop new medical cannabis varieties - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BreedIT, Seach form KanaboSeed to develop new medical cannabis varieties

BreedIT Corp through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, is pleased to announce the formation of KanaboSeed Ltd., a joint venture with Seach Ltd, a leading Israeli medical Cannabis breeder.

KanaboSeed was formed to research and develop new breeds of medical Cannabis to meet the requests of physicians and other medical practitioners. Strains developed under the KanaboSeed brand will be commercialized directly, while those created for third parties will generate royalty payments. BreedIT Ltd and Seach Ltd. have equal ownership in KanaboSeed Ltd.

Dr. Oded Sagee, Chief Executive Officer of BreedIT LTD, commented, "We are very excited about our partnership with Seach – their achievements in the breeding and growing of medical Cannabis are extensive. We formed KanaboSeed to leverage the expertise of both of our companies to pursue the significant opportunities in the medical Cannabis market."

Dr. Sagee continued and added, "Dedication to the ethical production of high quality, consistent seed strains is critical as we turn our focus to the development of innovative Cannabis seeds for the medical community. BreedIT is being advised by its Scientific Advisory Board members on various scientific methods and issues. Our access to the horticultural expertise and farming resources of Seach will be invaluable as we begin to breed new Cannabis strains."

Mr. Shay Avraham Sarid, Head of Research and Development at Seach, also commented on the announcement, stating "I am so pleased to be working with the BreedIT team. They are pioneers in the field and their technology is cutting-edge. We have generated a substantial amount of data around the growth and use of medicinal Cannabis on our farms over the past 10 years, and although we have only just begun to harness the power of the iBreedIT technology, the results to date have been remarkable."